Obesity

obesity overweight weight loss weigh

Biotech

Versant unveils Pep2Tango, a biotech with next-gen obesity hopes

Versant has unveiled Pep2Tango, a biotech developing next-gen obesity therapeutics with multiple targets to overcome GLP-1 limitations.

Gabrielle Masson Nov 21, 2024 11:11am

graphic image of different colored hands shaking

Pfizer, Flagship return to obesity as part of 10-program collab

Nov 20, 2024 8:05am

Two injectable medications with a tape measure wrapped around them

Gubra reveals early data for once-weekly obesity asset

Nov 13, 2024 5:56pm

money cash coins dollars

Metsera follows phase 1 weight loss data with $215M series B

Nov 13, 2024 9:15am

AstraZeneca still 'playing to win' in obesity, execs say

Nov 4, 2024 11:49am

Graphic of two hands shaking under a red and purple light

In $285M deal, Novo taps Ascendis to help create monthly GLP-1

Nov 4, 2024 8:43am